October PharmaE Past Earnings Performance

Past criteria checks 3/6

October PharmaE has been growing earnings at an average annual rate of 21.1%, while the Pharmaceuticals industry saw earnings growing at 15.1% annually. Revenues have been growing at an average rate of 18.1% per year. October PharmaE's return on equity is 25.6%, and it has net margins of 11.3%.

Key information

21.1%

Earnings growth rate

21.2%

EPS growth rate

Pharmaceuticals Industry Growth9.8%
Revenue growth rate18.1%
Return on equity25.6%
Net Margin11.3%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How October PharmaE makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

CASE:OCPH Revenue, expenses and earnings (EGP Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,1931351810
30 Jun 241,1301521840
31 Mar 241,0731591760
31 Dec 231,0121501710
30 Sep 238911311620
31 Mar 237611071490
31 Dec 227271141420
30 Sep 227091141380
31 Mar 226691141300
31 Dec 216551201240
30 Sep 216511231250
30 Jun 216191311080
31 Mar 215891211000
31 Dec 20543881050
30 Sep 20527791000
30 Jun 20527621100
31 Mar 20529381170
31 Dec 19523341130
30 Sep 19499171090
30 Jun 1946281030
31 Mar 1942618900
31 Dec 1840118890
30 Sep 1835521830
30 Jun 1833925910
31 Mar 18346341000
31 Dec 1735045990
30 Sep 17351521120
30 Jun 17337501040
31 Mar 1730242950
31 Dec 1628835950
30 Sep 1626624850
30 Jun 1625619870
31 Mar 1625820870
31 Dec 1524416840
30 Sep 1523922760
30 Jun 1523117780
31 Mar 1521410760
31 Dec 142028710
30 Sep 1420310740
30 Jun 1419613640
31 Mar 1420216640
31 Dec 1320018610

Quality Earnings: OCPH has high quality earnings.

Growing Profit Margin: OCPH's current net profit margins (11.3%) are lower than last year (14.8%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: OCPH's earnings have grown significantly by 21.1% per year over the past 5 years.

Accelerating Growth: OCPH's earnings growth over the past year (3%) is below its 5-year average (21.1% per year).

Earnings vs Industry: OCPH earnings growth over the past year (3%) did not outperform the Pharmaceuticals industry 37.9%.


Return on Equity

High ROE: OCPH's Return on Equity (25.6%) is considered high.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 05:15
End of Day Share Price 2024/12/22 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

October Pharma S.A.E is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution